SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats-Reference-Cited by-同舟云学术

SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats

Published:2017-10 Issue: Volume:333 Page:43-50
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Sa-nguanmoo Piangkwan,Tanajak Pongpan,Kerdphoo Sasiwan,Jaiwongkam Thidarat,Pratchayasakul Wasana,Chattipakorn Nipon,Chattipakorn Siriporn C.

Funder

Thailand Research Fund

Chiang Mai University

National Science and Technology Development Agency Thailand

Chiang Mai University Center of Excellence Award

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference27 articles.

1. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial;Bailey;BMC Med.,2013

2. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Abeta oligomers;Bomfim;J. Clin. Invest.,2012

3. SGLT2 inhibition—a novel strategy for diabetes treatment;Chao;Nat. Rev. Drug Discov.,2010

4. The role of oxidative stress in Parkinson's disease;Dias;J. Parkinsons Dis.,2013

5. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge;Friedewald;Clin. Chem.,1972

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges;Life Sciences;2024-10

2. Effect of sodium glucose Co-transporter 2 inhibitor use on anthropometric measurements and blood glucose in obese and non-obese type 2 diabetic patients;Clinical Nutrition ESPEN;2024-10

3. Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes;Journal of Diabetes Investigation;2024-09-10

4. Association of sodium‐glucose cotransporter 2 inhibitors with risk of incident dementia and all‐cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks;Diabetes, Obesity and Metabolism;2024-09-09

5. SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system;Translational Neurodegeneration;2024-08-09